In our present study, we have successfully employed two virtual screening methods to identify novel scaffolds that simultaneously bind the two receptors—adenosine A2A receptor and dopamine D2 receptor—implicated in the PD pathophysiology [13–21]. This evidence concerns the gene DRD2 and Parkinson disease.